[Neurological Manifestations of COVID-19: Meningoencephalitis and Encephalopathy].
Journal
Brain and nerve = Shinkei kenkyu no shinpo
ISSN: 1881-6096
Titre abrégé: Brain Nerve
Pays: Japan
ID NLM: 101299709
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
23
7
2022
Statut:
ppublish
Résumé
Coronavirus disease (COVID-19) causes neurological symptoms in a high percentage of patients and is associated with various types of encephalitides and encephalopathies, which are etiologically classified into (a)direct infection of the central nervous system with severe acute respiratory syndrome coronavirus 2 and resultant meningoencephalitis (this is a rare presentation), (b)COVID-19-induced cytokine storms, which trigger endothelial cell injury, blood-brain barrier disruption, and microangiopathy and consequent encephalopathy and, (c)autoimmune encephalitis secondary to para- or post-infectious mechanisms that play a key role during the acute or post-COVID-19 phase. Notably, some patients present with neurological symptoms as the first manifestation. Radiologically characteristic encephalitides and encephalopathies, such as acute necrotizing encephalopathy, acute disseminated encephalomyelitis, posterior reversible encephalopathy syndrome, and clinically mild encephalitis/encephalopathy with a reversible splenial lesion are also complicated by COVID-19. Further investigations and appropriate treatments are warranted in patients with COVID-19, who develop new neurological symptoms.
Identifiants
pubmed: 35860930
pii: 1416202137
doi: 10.11477/mf.1416202137
doi:
Types de publication
Case Reports
Journal Article
Langues
jpn
Sous-ensembles de citation
IM